Overview

  • Breast cancer begins when cells grow out of control, most frequently in the lobules (glands that produce milk) or the ducts (tubes that carry milk to the nipple). The cancer can spread (metastasize) through blood vessels and lymph vessels.
  • Breast cancer is the second most common cancer in American women, after skin cancers. Today, the average risk of a woman in the U.S. developing breast cancer is about 12%, or 1 in 8 women. Breast cancer can also occur in men.
  • In addition to chemotherapy and hormone therapy, there are newer, effective treatments that can attack specific breast cancer cells without harming normal cells. A targeted therapy is a drug designed to attack a certain molecular agent or pathway involved in the development of cancer. Currently, these targeted methods are commonly used in combination with traditional chemotherapy in patients whose cancer have the specific markers that these drugs are designed to target. Targeted therapies offer promise for current and future breast cancer treatments.

Our Fight for Patients – Breast Cancer

Metastasis is the primary cause of death from breast cancer. Our goal is to inhibit activation of invasive carcinoma causing cells by blocking TIE2-expressing macrophages thereby preventing further metastasis and potentially improving clinical outcomes in combination with chemotherapy.

Breast Cancer Clinical Studies:

Breast Cancer Patient Resources:

American Cancer Society
CANCERcare
Cancer Support Community
NORD
rare Clinical Diseases Research Network
Global Genes

On this page you may select links to content published by persons not affiliated with Deciphera. The views expressed in these materials are those of the author and do not reflect the views of Deciphera. Additionally, the information contained in these materials may not be current. Deciphera disavows any obligation to correct or to update the information contained in these materials.